| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $766.9M | -1.2% |
| Cost of Revenue | $197.4M | -22.6% |
| Gross Profit | $569.5M | +9.2% |
| R&D Expense | $196.6M | +10.0% |
| SG&A Expense | $216.2M | +36.0% |
| Operating Income | $9.0M | -88.5% |
| Pre-tax Income | $103.9M | +1711.2% |
| Income Tax | -$162.7M | -2360.6% |
| Net Income | $266.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $473.7M | -44.5% |
| Short-term Investments | $584.0M | -15.6% |
| Accounts Receivable | $23.5M | +31.7% |
| Current Assets | $1.14B | -29.5% |
| Total Assets | $2.47B | -15.5% |
| Current Liabilities | $138.9M | +21.5% |
| Total Liabilities | $1.35B | -25.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $255.7M | -6.4% |
| Capital Expenditures | $103.1M | +9.5% |
| Investing Cash Flow | $104.9M | +128.7% |
| Financing Cash Flow | -$744.8M | -259.6% |
| Free Cash Flow | $152.6M | -14.7% |
| — |
| EPS (Basic) | $2.09 | — |
| EPS (Diluted) | $1.34 | — |
| Stockholders' Equity |
| $1.12B |
| +0.9% |